Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Mineralys Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 166 | 193 | +27 |
| Shares | 65.7M | 79.3M | +13.6M (+20.8%) |
| Value | $888.8M | $3.01B | +$2.12B (+238.4%) |
New holders (42)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (15)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Dark Forest Capital Management LP | 126,726 | $1.71M |
| Woodline Partners LP | 87,868 | $1.19M |
| UBS Oconnor LLC | 79,723 | $1.08M |
| Walleye Capital LLC | 73,921 | $1.00M |
| Gsa Capital Partners LLP | 48,401 | $655.0K |
| Man Group plc | 21,852 | $295.7K |
| Intech Investment Management LLC | 21,629 | $292.6K |
| Fox Run Management, L.L.C. | 16,243 | $219.8K |
| STRS Ohio | 15,400 | $208.4K |
| Quadrature Capital Ltd | 11,987 | $162.4K |
| Group One Trading, L.P. | 10,137 | $137.2K |
| FNY Investment Advisers, LLC | 1,500 | $20.0K |
| Raymond James Financial Inc | 141 | $1.91K |
| Fifth Third Bancorp | 61 | $825 |
| National Bank of Canada | 7 | $95 |